Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,476.71
+6.090.41%
Number of Gainers:10
Number of Losers:8
Number of Flat:1
PE:- -
High:1,484.26
Open:1,470.85
Low:1,469.38
Close:1,470.74
Volume:103.18M
Turnover:3.25B
Market Cap:1.21T
Float Cap:1.19T

Loading ...

3 Things You Need to Know If You Buy Pfizer Today

Motley Fool
·
Sep 16

3 Magnificent S&P 500 Dividend Stocks Down as Much as 60% to Buy and Hold Forever

Motley Fool
·
Sep 16

Hong Kong Stocks Alert | HENLIUS (02696) Surges Over 9% Intraday Amid Reports of HLX43 Licensing Negotiations with Johnson & Johnson and Roche

Stock News
·
Sep 16

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots

Benzinga_recent_news
·
Sep 16

NANO MRNA Advances RUNX1 mRNA Clinical Trial for Osteoarthritis

TIPRANKS
·
Sep 16

Why Ocugen Stock Zoomed 12% Higher Today

Motley Fool
·
Sep 16

Pantera Lithium Advances Strategic Sale and U.S. Expansion

TIPRANKS
·
Sep 16

Press Release: Lakeland Fire + Safety Completes Acquisitions of Arizona PPE Recon, Inc. and California PPE Recon, Inc.

Dow Jones
·
Sep 16

Mixed options sentiment in Pfizer with shares down 0.44%

TIPRANKS
·
Sep 15

Correction to Gilead Sciences Headline on Aug. 7

Dow Jones
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Sep 15

Ocugen Shares up 10.8% After Licensing Deal for Ophthalmic Gene Therapy in South Korea

THOMSON REUTERS
·
Sep 15

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

TIPRANKS
·
Sep 15

Lakeland Industries Secures $5.6 Million Contract with Hong Kong Fire Services for Protective Gear Maintenance

Reuters
·
Sep 15

Lakeland Fire + Safety Awarded USD $5.6 Million Contract From Hong Kong Fire Services Department

THOMSON REUTERS
·
Sep 15

AstraZeneca PLC (AZN.US) Suspends UK Investment Plan, Faces Fresh Rating Downgrade

Stock News
·
Sep 15

Pfizer Inc. Announces New Findings on Myocarditis and COVID-19 Vaccine Safety in Latest Clinical Study

Reuters
·
Sep 15

Johnson & Johnson Unveils Promising Phase 3 Trial Results for Seltorexant in Treating Major Depressive Disorder with Insomnia Symptoms at 2025 Psych Congress

Reuters
·
Sep 15

Wall Street Analysts Are Bullish on Top Consumer Goods Picks

TIPRANKS
·
Sep 15

How Bad Is This Sector's Health Scare? -- WSJ

Dow Jones
·
Sep 15